Literature DB >> 22720222

Non-apoptotic routes to defeat cancer.

Jennifer L Guerriero1, Dara Ditsworth, Wei-Xing Zong.   

Abstract

The mechanism of tumor cell death after treatment with DNA alkylating agents in vivo previously remained largely unknown. We demonstrate that tumor regression after chemotherapy occurs via sporadic necrosis and relies on activation of innate immunity in a manner dependent on high mobility group box 1 protein (HMGB1).

Entities:  

Year:  2012        PMID： 22720222      PMCID： PMC3376957          DOI： 10.4161/onci.1.1.17885

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN： 2162-4011            Impact factor:   8.110


  10 in total

Review 1.  Death by a thousand cuts: granzyme pathways of programmed cell death.

Authors:  Dipanjan Chowdhury; Judy Lieberman
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

Review 2.  Apoptosis in cancer.

Authors:  S W Lowe; A W Lin
Journal:  Carcinogenesis       Date:  2000-03       Impact factor: 4.944

3.  Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.

Authors:  David G DeNardo; Donal J Brennan; Elton Rexhepaj; Brian Ruffell; Stephen L Shiao; Stephen F Madden; William M Gallagher; Nikhil Wadhwani; Scott D Keil; Sharfaa A Junaid; Hope S Rugo; E Shelley Hwang; Karin Jirström; Brian L West; Lisa M Coussens
Journal:  Cancer Discov       Date:  2011-06-01       Impact factor: 39.397

Review 4.  The role of apoptosis in cancer development and treatment response.

Authors:  J Martin Brown; Laura D Attardi
Journal:  Nat Rev Cancer       Date:  2005-03       Impact factor: 60.716

5.  DNA alkylating therapy induces tumor regression through an HMGB1-mediated activation of innate immunity.

Authors:  Jennifer L Guerriero; Dara Ditsworth; Joseph M Catanzaro; Gregory Sabino; Martha B Furie; Richard R Kew; Howard C Crawford; Wei-Xing Zong
Journal:  J Immunol       Date:  2011-02-07       Impact factor: 5.422

6.  Chemotherapy induces tumor clearance independent of apoptosis.

Authors:  Jennifer L Guerriero; Dara Ditsworth; Yongjun Fan; Fangping Zhao; Howard C Crawford; Wei-Xing Zong
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

Review 7.  The roles of therapy-induced autophagy and necrosis in cancer treatment.

Authors:  Ravi K Amaravadi; Craig B Thompson
Journal:  Clin Cancer Res       Date:  2007-12-15       Impact factor: 12.531

8.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation.

Authors:  Paola Scaffidi; Tom Misteli; Marco E Bianchi
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

Review 9.  Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation.

Authors:  G Solinas; G Germano; A Mantovani; P Allavena
Journal:  J Leukoc Biol       Date:  2009-09-09       Impact factor: 4.962

10.  Autophagy regulates selective HMGB1 release in tumor cells that are destined to die.

Authors:  J Thorburn; H Horita; J Redzic; K Hansen; A E Frankel; A Thorburn
Journal:  Cell Death Differ       Date:  2008-10-10       Impact factor: 15.828
  10 in total
  5 in total

Review 1.  How to control self-digestion: transcriptional, post-transcriptional, and post-translational regulation of autophagy.

Authors:  Yuchen Feng; Zhiyuan Yao; Daniel J Klionsky
Journal:  Trends Cell Biol       Date:  2015-03-08       Impact factor: 20.808

2.  Quantitative chemical proteomics profiling of de novo protein synthesis during starvation-mediated autophagy.

Authors:  Jigang Wang; Jianbin Zhang; Yew-Mun Lee; Pin-Lang Koh; Shukie Ng; Feichao Bao; Qingsong Lin; Han-Ming Shen
Journal:  Autophagy       Date:  2016-07-27       Impact factor: 16.016

Review 3.  Necrosis, and then stress induced necrosis-like cell death, but not apoptosis, should be the preferred cell death mode for chemotherapy: clearance of a few misconceptions.

Authors:  Ju Zhang; Xiaomin Lou; Longyu Jin; Rongjia Zhou; Siqi Liu; Ningzhi Xu; D Joshua Liao
Journal:  Oncoscience       Date:  2014-07-03

Review 4.  Trial Watch: Proteasomal inhibitors for anticancer therapy.

Authors:  Florine Obrist; Gwenola Manic; Guido Kroemer; Ilio Vitale; Lorenzo Galluzzi
Journal:  Mol Cell Oncol       Date:  2014-12-01

5.  Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set.

Authors:  Abdul Qader Sukkurwala; Sandy Adjemian; Laura Senovilla; Mickaël Michaud; Sabrina Spaggiari; Erika Vacchelli; Elisa Elena Baracco; Lorenzo Galluzzi; Laurence Zitvogel; Oliver Kepp; Guido Kroemer
Journal:  Oncoimmunology       Date:  2014-04-16       Impact factor: 8.110
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.